Catalyst Capital Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Catalyst Capital Advisors’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,400	Closed	-$2.97M	–	453
2023 Q2	$2.97M	Buy	+10,400	New	+$2.89M	0.09%	96
2019 Q3	–	Sell	-280	Closed	-$16K	–	496
2019 Q2	$16K	Hold	280	–	–	﹤0.01%	281
2019 Q1	$9K	Buy	+280	New	+$9.3K	﹤0.01%	310

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Catalyst Capital Advisors's SWAV Position: Q3 2023 in Review

Catalyst Capital Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 10,400 shares — an estimated $2.97M sold.

Catalyst Capital Advisors first reported a position in SWAV in Q1 2019 and held it in 3 quarters. The position peaked at $2.97M in Q2 2023. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

Catalyst Capital Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Catalyst Capital Advisors sold 10,400 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $2.97M.
Catalyst Capital Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Catalyst Capital Advisors's Shockwave Medical, Inc. Common Stock position peaked at $2.97M in Q2 2023.
412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Catalyst Capital Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.